Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.76.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.38.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.38.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.357NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.46NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.188NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.494NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.167NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.267NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.165NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.554NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.243.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2.5.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.118NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.501NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.226NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.546NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.194NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.429.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.9 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.25.1.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.203NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.157NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.515NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
B.1.287NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-2582.97Singapore
B.1.1.431NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.170NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.506NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.6.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.438.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.111NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.336NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.400.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.537NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.548NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.24.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.492NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.540NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.487NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AM.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used